Hikal Ltd Hits Intraday High with 10.75% Surge on 12 Feb 2026

5 hours ago
share
Share Via
Hikal Ltd recorded a robust intraday performance on 12 Feb 2026, surging to a day’s high of Rs 210.5, marking a significant 10.75% gain. The stock outperformed its Pharmaceuticals & Biotechnology sector peers and demonstrated heightened volatility throughout the trading session.
Hikal Ltd Hits Intraday High with 10.75% Surge on 12 Feb 2026

Intraday Trading Highlights

Hikal Ltd opened the day with a positive gap, rising 2.75% from its previous close, signalling strong buying momentum from the outset. The stock maintained an upward trajectory, touching an intraday peak of Rs 210.5, reflecting a 10.07% increase from the opening price. This surge was accompanied by notable volatility, with the weighted average price indicating an intraday volatility of 19.87%, underscoring active trading interest and price fluctuations during the session.

The stock’s performance today outpaced the Pharmaceuticals & Biotechnology sector by 9.79%, highlighting its relative strength amid a broadly cautious market environment. This marks the fourth consecutive day of gains for Hikal Ltd, cumulatively delivering a 17.07% return over this period, a notable streak given the sector’s mixed performance.

Technical Positioning and Moving Averages

From a technical perspective, Hikal Ltd’s current price stands above its 5-day and 20-day moving averages, indicating short-term bullish momentum. However, it remains below the longer-term 50-day, 100-day, and 200-day moving averages, suggesting that while recent trading has been positive, the stock has yet to reclaim its longer-term trend lines. This positioning reflects a market still digesting recent price movements and awaiting further directional cues.

Market Context and Broader Indices

The broader market, represented by the Sensex, opened lower by 265.21 points and was trading at 83,839.46, down 0.47% at the time of reporting. Despite this, the Sensex remains close to its 52-week high, just 2.77% shy of the peak level of 86,159.02. The index has been on a three-week consecutive rise, gaining 2.82% over this period, although it currently trades below its 50-day moving average. The 50-day moving average itself remains above the 200-day moving average, indicating an overall positive medium-term trend for the benchmark.

Our current Stock of the Month is out! This Large Cap from Automobiles - Passenger Cars emerged as the single best opportunity from our elite universe. Get the details now!

  • - Current monthly selection
  • - Single best opportunity
  • - Elite universe pick

Get the Full Details →

Comparative Performance Metrics

Examining Hikal Ltd’s recent performance relative to the Sensex reveals a mixed trend. The stock’s one-day gain of 10.38% starkly contrasts with the Sensex’s decline of 0.47%. Over the past week, Hikal Ltd has advanced 10.49%, outperforming the Sensex’s modest 0.63% rise. However, over longer time frames, the stock has lagged the benchmark. The one-month return stands at -1.77% versus the Sensex’s -0.05%, while the three-month performance shows a decline of 11.36% compared to the Sensex’s -0.75%. Over the past year, Hikal Ltd has fallen 40.88%, significantly underperforming the Sensex’s 10.06% gain.

Year-to-date, the stock is down 6.96%, compared with the Sensex’s 1.62% decline. Over three and five years, Hikal Ltd’s returns of -36.16% and 26.52% respectively, trail the Sensex’s 38.16% and 62.65%. Even on a ten-year horizon, while Hikal Ltd has delivered a substantial 146.23% gain, it remains well behind the Sensex’s 264.73% appreciation.

Mojo Score and Rating Update

Hikal Ltd currently holds a Mojo Score of 23.0, categorised as a Strong Sell. This represents a downgrade from its previous Sell rating, which was revised on 14 Nov 2025. The company’s Market Cap Grade is rated 3, reflecting its mid-tier market capitalisation within the Pharmaceuticals & Biotechnology sector. These metrics provide a quantitative assessment of the stock’s risk and quality profile based on MarketsMOJO’s proprietary evaluation system.

Hikal Ltd or something better? Our SwitchER feature analyzes this small-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!

  • - SwitchER analysis complete
  • - Superior alternatives found
  • - Multi-parameter evaluation

See Smarter Alternatives →

Volatility and Trading Dynamics

The heightened intraday volatility of 19.87% reflects significant price swings during the session, indicative of active participation from traders and investors. Such volatility often accompanies stocks experiencing sharp directional moves, as seen with Hikal Ltd’s 10.75% intraday gain. This dynamic can present both opportunities and risks, depending on market conditions and individual trading strategies.

Summary of Today’s Market Environment

While Hikal Ltd demonstrated strong relative strength today, the broader market environment remains cautious. The Sensex’s slight decline and its position below the 50-day moving average suggest some near-term pressure on the benchmark. Nonetheless, the index’s proximity to its 52-week high and the positive medium-term moving average alignment indicate underlying resilience in the market.

Hikal Ltd’s performance today stands out against this backdrop, driven by its own trading momentum and sector-specific factors. The stock’s ability to sustain gains above short-term moving averages may be a key focus for market participants monitoring its price action in the coming sessions.

Conclusion

On 12 Feb 2026, Hikal Ltd delivered a notable intraday rally, reaching Rs 210.5 and posting a 10.75% gain amid volatile trading conditions. The stock’s outperformance relative to its sector and the broader market highlights its current trading strength. Despite this, longer-term performance metrics and technical indicators suggest a cautious stance remains warranted. The recent downgrade to a Strong Sell rating further underscores the need for careful analysis of the stock’s risk profile.

Investors and traders observing Hikal Ltd’s price movements will likely continue to monitor its ability to maintain momentum above key moving averages and manage volatility in the near term.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Are Hikal Ltd latest results good or bad?
Feb 11 2026 07:36 PM IST
share
Share Via
Hikal Ltd is Rated Strong Sell
Feb 07 2026 10:10 AM IST
share
Share Via
When is the next results date for Hikal Ltd?
Feb 05 2026 11:17 PM IST
share
Share Via